We have located links that may give you full text access.
English Abstract
Journal Article
[Neuropsychiatric drugs during pregnancy].
Revue Médicale de Bruxelles 2001 September
As studies concerning the innocuousness of neuropsychiatic drugs during pregnancy are sometimes contradictory and difficult to interpret, the guiding line to follow is that the risk incurred by the foetus must be inferior to that of an untreated maternal pathology. Categories such as "anticonvulsivants", benzodiazepins or lithium may increase, particularly during the first term, the risk of some malformations. IMAOs and psychostimulants are to be avoided. As for antidepressants, some SSRIs such as fluotexin or citalopram will be preferred as far as possible. Neuroleptics will only be continued in case of major depressions and in small quantities. Exposure to some categories of drugs in the third term will mainly lead to neonatal symptoms. Finally, the importance of psychological or psychiatric support must be stressed throughout pregnancy.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app